Nörolojik Hastalıklar ve Probiyotik-Prebiyotik Kullanımı

Yıl 2018, Cilt: 3 Sayı: 2, 1 - 29, 30.12.2018

Ümmühan Akkaya Esra Köseler Beyaz

Öz

Probiyotikler; mikrobiyal dengeyi iyileştirerek yararlı etkileri olan mikroorganizmalardır. Prebiyotikler ise; insanlarda sindirim enzimleri tarafından sindirilemeyen ve bazı yararlı bakteri gruplarının aktivitesini seçici olarak geliştiren besinlerdir. Probiyotik tüketiminin, bağışıklık cevabını arttırmak, koloniyi dengelemek, hücrelerin endojen savunma kapasitelerini artırmak gibi birçok olumlu etki gösterdiği bildirilmiştir. Prebiyotiklerin amacı ise probiyotik bakterilerin büyümesini, böylece gastrointestinal ve bağışıklık sistemlerinin geliştirilmesini sağlamaktır. En yaygın olarak kullanılan probiyotik ve prebiyotikler; Lactobacillus ve Bifidobacterium cinsi laktik asit bakterilerdir. Prebiyotikler ise doğal olarak besin maddelerinde bulunmaktadırlar. Birçok hastalığın önlenmesinde probiyotik ve prebiyotikler kullanılmaktadır. Multiple skleroz, alzheimer, migren ve parkinson hastalığı gibi pekçok nörolojik hastalık grubunda da probiyotik ve prebiyotik takviyelerinin olumlu sonuçları görülmektedir.

Anahtar Kelimeler

Probiyotik, prebiyotik, nörolojik hastalıklar

Kaynakça

• Abraham, D., Felszeghy, K., Feher, J., Radak, Z. (2016). Interval training and probiotic supplementation a new prospect in the prevention of Alzheimers Disease: YI-07. Free Radical Biology and Medicine, 96:17–18.
• Abraham, D., Radak, Z., Feher, J. (2016). Exercise and Probiotics Attenuate the Development of Alzheimer Disease in Mice. Free Radical Biology and Medicine, 100:165.
• Akbari, E., Asemi, Z., Daneshvar, R. K., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., Salami, M. (2016). Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. Front Aging Neurosci, 10; 8: 256.
• Allen, S. J., Martinez, E. G., Gregorio, G. V., Dans, L. F. (2010). Probiotics for treating acute infectious diarrhoea. The Cochrane Collaboration, 10(11): 1-96.
• Al-Sheraji, S. H., Ismail, A., Manap, M. Y., Mustafa, S., Yusof, R. M., Hassan, F. A. (2013). Prebiotics as functional foods: A review. Journal of Functional Foods, 5(4): 1542-1553.
• Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.M., Bertalan, M., Borruel, N., Casellas, F., Fernandez, L., Gautier, L., Hansen, T., Hattori, M., Hayashi, T., Kleerebezem, M., Kurokawa, K., Leclerc, M., Levenez, F., Manichanh, C., Nielsen, H.B., Nielsen, T., Pons, N., Poulain, J., Qin, J.J., Sicheritz-Ponten, T., Tims, S., Torrents, D., Ugarte, E., Zoetendal, E.G., Wang, J., Guarner, F., Pedersen, O., de Vos, W.M., Brunak, S., Dore, J., Weissenbach, J., Ehrlich, S.D., Bork, P., Consortium, M. (2011). Enterotypes of the human gut microbiome. Nature, 473:174–180.
• Atarashi, K., Tanoue, T., Oshima, K., Suda , W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S.,Hase, K., Kim , S., Fritz , J. V., Wilmes ,P., Ueha, S ., Matsushima, K .,Ohno, H., Olle, B., Sakaguchi, S.,Taniguchi, T., Morita, H., Hattori, M., Honda, K. (2013). Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature, 500 (7461): 232-6.
• Barboza, J. L., Okun, M. S., Moshiree, B. (2015). The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease. Expert Opinion on Pharmacotherapy, 16(16): 2449-64.
• Barichella, M., Pacchetti, C., Bolliri, C., Cassani, E., Lorio, L., Pusani, C., Pinelli, G ., Privitera, G., Cesari, L., Faierman, S. A., Caccialanza, R., Pezzoli, G., Cereda, E. (2016). Probiotics and prebiotic fiber for constipation associated with Parkinson disease. American Academy of Neurology, 87(12): 1274-80.
• Barreiro, L. C., Eixarch, H., Montalban, X., Espejo, C. (2018). Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis. Autoimmunity Reviews, 17(2): 165-174.
• Carrasco, A. J. P., Timmermann, L., Pedrosa, D. J. (2018). Management of constipation in patients with Parkinson’s disease. Nature Partner Journals Parkinsons Diseases, 4:6.
• Ceapa, C., Wopereis, H., Rezaïki, L., Kleerebezem, M., Knol, J., Oozeer, R. (2013). Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health. Best Practice & Research Clinical Gastroenterology, 27(1): 139-155.
• Clavel, T., Fallani, M., Lepage, P., Levenez, F., Mathey, J., Rochet, V., Serezat, M., Sutren, M., Henderson, G., Pelissero, C.B., Tondu, F., Blaut, M., Dore, J., Coxam, V. (2005). Isoflavones and Functional Foods Alter the Dominant Intestinal Microbiota in Postmenopausal Women. Human Nutrition and Metabolism, 135(12), 2786-92.
• Corr, S. C., Li, Y., Riedel, C. U., O’Toole, P. W., Hill, C., Gahan, C. G. (2007). Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci.,104: 7617-7621.
• Cuervo, A., Valde, L., Salazar, N., Gavila, C. R., Madiedo, P. R., Gueimonde, M., Gonzalez, S. (2014). Pilot Study of Diet and Microbiota: Interactive Associations of Fibers and Polyphenols with Human Intestinal Bacteria. Journal of Agricultural and Food Chemistry, 62, 5330-5336.
• Dai, Y. J.,Wang, H. Y.,Wang, X. J., Kaye , A. D., Sun, Y. H. (2017). Potential Beneficial Effects of Probiotics on Human Migraine Headache: A Literature Review. Pain Physician, 20(2):251-255.
• Duncan, S., Flint, H. (2003). Probiotics and prebiotics and health in ageing populations. Maturitas, 75:44-50.
• Farhadı, A., Banan, A., Fıelds, J., Keshavarzıan, A. (2003). Intestinal barrier: An interface between health and disease. Journal of Gastroenterology and Hepatology, 18: 479–497.
• Fleming, J. O., Isaak, A., Lee, J. E., Luzzio, C. C., Carrithers, M. D., Cook, T. D. (2011). Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler, 17: 743-54.
• Fonteles, T. H., Rodrigues, S. (2018). Prebiotic in fruit juice: processing challenges, advances, and perspectives. Current Opinion in Food Science, 22:55-61. Forsyth, C. B, Shannon, K. M., Kordower, J. H. (2011). Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease. PLoS One, 6:28032.
• Gareau, M. G,Wine, E., Rodrigues, D. M., Cho J. H, Whary, M. T., Philpott, D. J., MacQueen, G., Sherman, P. M. (2011). Bacterial infection causes stress-induced memory dysfunction in mice. Gut Microbiota, 60: 307-317.
• Guarner, F., Bourdet, S. R., Brandtzaeg, P., Gill ,H. S., McGuirk, P., Eden ,W., Versalovic, J., Weinstock, J. V., Rook, G. A. (2006). Mechanisms of disease: the hygiene hypothesis revisited. Nature Clinicial Practice Gastroenterology & Hepatology, 3(5): 275-84.
• Hemert, S., Breedveld, A.C., Rovers, J. M. P., Vermeiden, J. P.W., Witteman, B. J. M., Smits, M. G., Roos, N. M. (2014). Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Frontiers in Neurology, 21;5: 241.
• Hemert, S., JVerwer, J., Schütz, B. (2013). Clinical Studies Evaluating Effects of Probiotics on Parameters of Intestinal Barrier Function. Advances in Microbiology, 3: 212-221.
• Hooper, L. V., Gordon, J. I. (2001). Commensal host-bacterial relationships in the gut. Science, 292: 1115–1118.
• Houser, M. C., Chang, J., Factor, S. A., Molho , E. S., Zabetian, C. P., Hill-Burns, E. M., Payami, H., Hertzberg , V. S., Tansey, M. G. (2018). Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson’s Disease. Movement Disorders.
• Hu, X., Wang, T., Jin, F. (2016). Alzheimer's disease and gut microbiota. Scıence Chına Life Sciences, 59(10): 1006-1023.
• Kaur, I. P., Chopra, K., Saini, A. (2002). Probiotics: potential pharmaceutical applications. Eur J Pharm Sci, 15:1–9.
• Keshavarzian, A., Green, S. J., Engen, P. A. (2015). Colonic bacterial composition in Parkinson’s disease. Mov Disord, 30: 1351–1360.
• Khoder, G., Menhali, A. A., Al-Yassir, F., Karam, S. M. (2016). Potential role of probiotics in the management of gastric ulcer. Exp Ther Med. 12:3–17.
• Kouchaki, E., Tamtaji, O. R., Salami, M., Bahmani, F., Kakhaki, R. D., Akbari, E., Ebrahimi, M. T., Jafari, P., Asemi, Z. (2017). Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition, 36(5): 1245-1249.
• Kurth, T., Winter, A. C., Eliassen, A. H., Dushkes, R., Mukamal, K. J.,Rimm, E. B., Willett, W. C., Manson, J. E., Rexrode, K. M. (2016). Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ, 353: 2610.
• Lavasani, S., Dzhambazov, B., Nouri, M., Fak, F., Buske, S., Molin, G., Thorlacius, H., Alenfall, J., Jeppsson, B., B. Westrom, A. (2010). Novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL10 producing regulatory T cells, PloS One 5: 9009.
• Lemarroy, C. C., Gutierrez, R. R., Robles, R. M., Rivera, A. M. (2016). Gastrointestinal disorders associated with migraine: A comprehensive review. World Journal Gastroenterology, 22(36): 8149-8160.
• Lemus, H. N., Warrington, A. E., Rodriguez, M. (2018). Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair. Neurol Clin, 36(1): 1-11.
• Ley, R. E., Turnbaugh, P. J., Klein, S., Gordon, J. I. (2006). Microbial ecology: human gut microbes associated with obesity. Nature, 444:1022–1023.
• Lipton, R. B., Stewart, W. F. (1993). Migraine in the United States: a review of epidemiology and health care use. Neurology, 1993; 43:6-10.
• Mancuso, C., Santangelo, R. (2017). Alzheimer's disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence. Pharmacological Research, 129: 329-336.
• Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J. F., Rougeot, C., Pichelin, M., Cazaubiel, M., Cazaubiel, J. M. (2011). Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticusR0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition, 105: 755–764.
• Mohammadi, A. A., Jazayeri, S., Khosravi, D. K., Solati, Z., Mohammadpour, N., Asemi, Z. (2015). The effects of probiotics on mental health and hypothalamic pituitary-adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr Neurosci.
• Mohtashem, S., Rafael, C., Raheleh, A., Javier, Y. (2010). Neuropeptides and other chemical mediators, and the role of anti-inflammatory drugs in primary headaches. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 9(3): 170-188.
• Monteith, T. S., Peter J. Goadsby, P.J. (2011). Acute Migraine Therapy: New Drugs and New Approaches. Current Treatment Options in Neurology, 13(1): 1–14.
• Notay, M., Foolad, N., Vaughn, A. R., Sivamani, R. K. (2017). Probiotics, Prebiotics, and Synbiotics for the Treatment and Prevention of Adult Dermatological Diseases. American Journal of Clinical Dermatology, 18(6): 721-732.
• Ohland, C. L., MacNaughton, W. K. (2010). Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol, 298:807–819.
• Ojetti, V., Laniro, G., Tortora, A., D'Angelo, G., Rienzo ,T. A., Bibbò, S., Migneco, A., Gasbarrini, A. (2014). The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: A randomized, double-blind, placebo-controlled trial. Journal Gastrointestinal and Liver Diseases, 23(4): 387-91.
• O’Shea, E. F., O’Connor, P. M., Raftis, E. J., O’Toole, P.W., Stanton, C., Cotter, P. D., Ross, R. P., Hill, C. (2011). Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius. J Bacteriol, 193: 6973-6982.
• Parashar, A., Udayabanu, M. (2017). Gut microbiota: Implications in Parkinson's disease. Parkinsonism Related Disorders, 38:1-7.
• Roman, P., Abalo, R., Marco, E. M., Cardona, D. (2018). Probiotics in digestive, emotional, and pain-related disorders. Behavioural Pharmacology, 2(3): 103-119.
• Pelletier, D., Hafler, D. A. (2012). Fingolimod for Multiple Sclerosis. The New England Journal of Medicine, 366(4): 339-47.
• Qiu, C., Ronchi, D., Fratiglioni, L. (2007). The epidemiology of the dementias: an update. Services research and outcomes, 20: 380-385.
• Roos, N. M., Giezenaar, C. G., Rovers, J. M., Witteman, B. J., Smits, M. G., Hemert, S. (2015). The effects of the multispecies probiotic mixture Ecologic®Barrier on migraine: results of an open-label pilot study. Beneficial Microbes, 6(5): 641-646.
• Routhiau, V. G., Rakotobe, S., Lecuyer, Mulder, E., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., Paepe, M., Brandi, G., Eberl, G., Snel, J., Kelly, D., Bensussan, N. C. (2009). The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses. Immunity Article, 31:677–689.
• Sanders, M. E., Benson, A., Lebeer, S., Merenstein, D. J., Klaenhammer, T. R. (2018). Shared mechanisms among probiotic taxa: implications for general probiotic claims. Current Opinion in Biotechnology, 49: 207-216.
• Sensenig, J., Marrongelle, J., Johnson, M., Staverosky, T. (2001). Treatment of Migraine with Targeted Nutrition Focused on Improved Assimilation and Elimination. Alternative Medicine Review, 6(5):488-94.
• Tankou, S. K., Regev, K.,Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., Vanande, I. P., Cook, S., Gandhi, R., Glanz, B., Stankiewicz, J., Weiner, H. L. (2018). Investigation of probiotics in multiple sclerosis. Multiple Sclerosis Journal, 24(1): 58-63.
• Tankou, S. K., Regev, K., Healy, B. C., Tjon, E., Laghi L., Cox, L. M., Kivisäkk, P., Pierre, I. V., Lokhande, H., Gandhi, R., Cook, S., Glanz, B., Stankiewicz, J., Weiner, H. L. (2018). A probiotic modulates the microbiome and immunity in multiple sclerosis. Annals of Neurology.
• Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain-Raspaud, S., Trotin, B., Naliboff, B., Mayer, E. A. (2013). Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology, 144:1394–1401.
• Timmerman, H. M., Koning, C. J., Mulder, L., Rombouts, F. M., Beynen, A. C. (2010). Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. International journal of food microbiology, 96:219-33.
• Tripathi, M. K., Giri, S. K. (2014). Probiotic functional foods: Survival of probiotics during processing and storage. Journal of Functional Foods, 9:225-241.
• Türkay, Ö. & Saka, M. (2016). Konstipasyon ve Diyet. Güncel Gastroenteroloji Dergisi, 20(3).
• Wang, T., Hu, X., Liang, S., Li, W., Wu, X., Wang, L., Jin, F. (2015). Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Beneficial Microbes, 6(5): 707-717.
• Zubillaga, M., Weill, R., Postaire, E., Goldman, C., Caro, R., Boccio, J. (2001). Effect of probiotics and functional foods and their use in different diseases. Nutrition Research, 21:569–579